These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7927754)
21. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. Karp DR; Long EO J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684 [TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Papageorgiou AC; Acharya KR; Shapiro R; Passalacqua EF; Brehm RD; Tranter HS Structure; 1995 Aug; 3(8):769-79. PubMed ID: 7582894 [TBL] [Abstract][Full Text] [Related]
23. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008 [TBL] [Abstract][Full Text] [Related]
24. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Fraser JD Nature; 1989 May; 339(6221):221-3. PubMed ID: 2785644 [TBL] [Abstract][Full Text] [Related]
25. Identification of critical residues of staphylococcal enterotoxin B for lymphomonocyte proliferation and cytokine production. Di Stefano A; Paulesu L; Niccolai N; Scarselli M; Soldani P; Neri P J Pept Res; 1998 Aug; 52(2):130-6. PubMed ID: 9727869 [TBL] [Abstract][Full Text] [Related]
26. Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Kozono H; Parker D; White J; Marrack P; Kappler J Immunity; 1995 Aug; 3(2):187-96. PubMed ID: 7648392 [TBL] [Abstract][Full Text] [Related]
27. Assessment of the functional regions of the superantigen staphylococcal enterotoxin B. Zhang L; Rogers TJ Toxins (Basel); 2013 Oct; 5(10):1859-71. PubMed ID: 24152989 [TBL] [Abstract][Full Text] [Related]
28. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. Abrahmsén L; Dohlsten M; Segrén S; Björk P; Jonsson E; Kalland T EMBO J; 1995 Jul; 14(13):2978-86. PubMed ID: 7542584 [TBL] [Abstract][Full Text] [Related]
29. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. Lamphear JG; Stevens KR; Rich RR J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895 [TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists. Rajagopalan G; Sen MM; David CS Infect Immun; 2004 Nov; 72(11):6733-7. PubMed ID: 15501813 [TBL] [Abstract][Full Text] [Related]
31. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC. Wang S; Li Y; Xiong H; Cao J Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523 [TBL] [Abstract][Full Text] [Related]
32. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells. Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802 [TBL] [Abstract][Full Text] [Related]
33. Structure-based design of a bispecific receptor mimic that inhibits T cell responses to a superantigen. Lehnert NM; Allen DL; Allen BL; Catasti P; Shiflett PR; Chen M; Lehnert BE; Gupta G Biochemistry; 2001 Apr; 40(14):4222-8. PubMed ID: 11284677 [TBL] [Abstract][Full Text] [Related]
34. Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA. Griggs ND; Pontzer CH; Jarpe MA; Johnson HM J Immunol; 1992 Apr; 148(8):2516-21. PubMed ID: 1560207 [TBL] [Abstract][Full Text] [Related]
35. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371 [TBL] [Abstract][Full Text] [Related]
36. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
37. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. Leder L; Llera A; Lavoie PM; Lebedeva MI; Li H; Sékaly RP; Bohach GA; Gahr PJ; Schlievert PM; Karjalainen K; Mariuzza RA J Exp Med; 1998 Mar; 187(6):823-33. PubMed ID: 9500785 [TBL] [Abstract][Full Text] [Related]
38. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Kim J; Urban RG; Strominger JL; Wiley DC Science; 1994 Dec; 266(5192):1870-4. PubMed ID: 7997880 [TBL] [Abstract][Full Text] [Related]
39. Site of nonrestrictive binding of SEA to class II MHC antigens. Pontzer CH; Russell JK; Jarpe MA; Johnson HM Int Arch Allergy Appl Immunol; 1990; 93(2-3):107-12. PubMed ID: 2099338 [TBL] [Abstract][Full Text] [Related]
40. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha. Krupka HI; Segelke BW; Ulrich RG; Ringhofer S; Knapp M; Rupp B Protein Sci; 2002 Mar; 11(3):642-51. PubMed ID: 11847286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]